Edition:
United States

Intrexon Corp (XON)

XON on New York Consolidated

19.57USD
28 Mar 2017
Change (% chg)

$-0.45 (-2.25%)
Prev Close
$20.02
Open
$19.70
Day's High
$20.23
Day's Low
$19.46
Volume
153,435
Avg. Vol
1,294,775
52-wk High
$38.60
52-wk Low
$18.55

Select another date:

Fri, Mar 10 2017

BRIEF-Intrexon creates Precigen

* Intrexon creates Precigen Inc and accelerates strategic review of structural options related to health assets

BRIEF-Intrexon Q4 loss per share $0.37

* Intrexon announces fourth quarter and full year 2016 financial results

BRIEF-Genvec says if merger agreement is terminated by either party, it would pay Intrexon a termination fee equal to $550,000

* If merger agreement is terminated by either party, Genvec must pay Intrexon a termination fee equal to $550,000 - SEC filing Source text: (http://bit.ly/2jbIZR1) Further company coverage:

BRIEF-Ziopharm and Intrexon announce cooperative research and development agreement with NCI utilizing sleeping beauty system to generate T Cells targeting Neoantigens

* Ziopharm and Intrexon announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T Cells targeting Neoantigens Source text for Eikon: Further company coverage:

BRIEF-Intrexon reports Q3 loss per share of $0.24

* Q3 revenue $49 million versus I/B/E/S view $51.7 million Source text for Eikon: Further company coverage:

BRIEF-Intrexon, Third Security amended services agreement dated as of Nov. 1 - SEC Filing

* On Oct 31, co & Third Security LLC executed an amendment to the services agreement dated as of November 1, 2015 - SEC Filing Source text for Eikon: (http://bit.ly/2eXKHXK) Further company coverage:

Intrexon says Brazil mosquito laboratory could protect millions

PIRACICABA, Brazil, Oct 26 Intrexon Corp's launch on Wednesday of a laboratory in Brazil capable of producing 60 million genetically-modified mosquitoes a week could help protect up to 3 million locals from mosquito-borne diseases like Zika and dengue, the company said.

Select another date:

More From Around the Web